Drug intelligence / Profile preview

Genta-Coll resorb

Development stage
Unknown
Lead developer
Resorba
Modality
Small Molecules
Administration
Implant, Topical
01

Overview

Genta-Coll resorb is a resorbable hemostatic collagen sponge implant containing the aminoglycoside antibiotic gentamicin sulfate. It is a local drug-device combination composed of equine-derived collagen fibrils and gentamicin sulfate. The collagen matrix acts as a physical hemostatic agent by activating blood coagulation upon contact with blood, while simultaneously serving as a local delivery vehicle that releases gentamicin to provide sustained, high local antibiotic concentrations at the surgical site. This dual action is designed to achieve rapid hemostasis and prevent or treat surgical site infections in clean or contaminated wounds, septic surgery, and high-risk surgical procedures (such as cardiothoracic, orthopedic, and vascular surgeries). While widely approved and marketed for surgical hemostasis and infection prophylaxis, a clinical trial investigating its use as an adjunct therapy for acute and chronic osteomyelitis of long bone shafts was terminated early due to recruitment challenges.

Brand names
Genta-Coll resorbGenta-Coll
Other names
gentamicin-collagen spongegentamicin-collagen implantgentamicin-collagen hemostatic sponge
02

Targets

Bacterial RibosomeBacterial 50S ribosomal subunit

Beyond the preview

Go deeper on Genta-Coll resorb.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genta-Coll resorb.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call